AD1208

Avelos Therapeutics Inc. · Phase 1 active Small molecule

At a glance

Generic name	AD1208
Sponsor	Avelos Therapeutics Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

AD1208 CI brief — competitive landscape report
AD1208 updates RSS · CI watch RSS
Avelos Therapeutics Inc. portfolio CI